New York, NY, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (NSAIDs, Analgesics, DMARDs, Corticosteroids and Other), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals)”. According to the report, the global rheumatology therapeutics market was valued at around USD 44.18 billion in 2017 and is expected to reach around USD 50.9 billion by 2022, growing at a CAGR of 2.9 % between 2016 and 2022.
Musculoskeletal conditions are a major burden on the individual, society and the healthcare service providers. These conditions result in joint inflammation, pain, swelling, and stiffness. Rheumatic disease is one of the leading causes of morbidity in around the world. People of all ages, genders, and races can have arthritis, and it is the leading cause of disability in the United States. More than 50 million adults and almost 300,000 children have arthritis or some other type of rheumatic disease. Rheumatic diseases are generally common among women and occur more frequently as people get older.
Browse through 99 Tables & 54 Figures spread over 110 Pages and in-depth TOC on "Global Rheumatology Therapeutics Market: Industry Type, Size, Share, Trends and Forecast 2016 – 2022”.
Request Free Sample copy of Global Rheumatology Therapeutics Market Report @ https://www.zionmarketresearch.com/sample/rheumatology-therapeutics-market
The growing burden of rheumatic diseases around the world is fostering the growth of rheumatology therapeutics market. A wide number of biosimilars and drugs under pipeline are fostering the growth of the market. However, high capital investments in drug development, stringent rules and regulations are slowing the growth of the market. Technologically enhanced products such as biologics and biosimilars are expected to present lucrative business opportunities in future.
On the basis of disease type, the global rheumatology therapeutics market is divided into rheumatoid arthritis, osteoarthritis, lupus, gout, ankylosing spondylitis and other. Rheumatoid arthritis disease has high prevalence rates than other disease and accounts for the major share in global rheumatology therapeutics market. On the basis of drug type the market is segmented into non-steroidal anti-inflammatory drugs, analgesics, disease modifying anti-rheumatic drugs, corticosteroids and other. DMARDs segment dominated the market in 2016 owing to their increased in use in the early stage of treatment. The distribution channel segment of rheumatology therapeutics includes a retail pharmacy, online pharmacy, and hospitals.
Browse the full "Rheumatology Therapeutics Market by Disease Type (Rheumatoid Arthritis, Osteoarthritis, Lupus, Gout, Ankylosing spondylitis and other), Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids and Others), Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2022.: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 – 2022." report at https://www.zionmarketresearch.com/report/rheumatology-therapeutics-market
North America emerged as the largest market for rheumatology therapeutics market and it accounted for a maximum market share of total revenue generated in 2016. North America rheumatology therapeutics market has a huge growth potential as the region has high incident rates of rheumatic diseases. Rheumatic arthritis affects more than 4.2 million Canadians. It is believed that the rate of arthritis in Canada will be greater affecting around 21.0% to 26.0% of the population by 2021. The U.S. represents the largest rheumatology therapeutics market in this region. As per Centers for Disease Control and Prevention, from 2013- 2015, an estimated 54.4 million people had some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia. In U.S. arthritis is one of the leading cause of disability it is projected to affect 78.4 million adults by 2040.
Europe is likely to be the second largest regional market and is expected to show strong growth in the years to come. Countries like Germany, France, and U.K. accounted for largest revenue share in rheumatology therapeutics market in Europe. Rheumatoid arthritis, lupus, and many other musculoskeletal conditions are the common cause of long-term pain and disability in the European countries and lead to significant medical costs. The growth of the market is majorly driven by increasing geriatric population, obesity and lack of physical activity. Moreover, advanced medical facilities and good economic conditions promote the growth in this region.
Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/rheumatology-therapeutics-market
The Asia Pacific is expected to witness the fastest growth in the near future. The growth is majorly due to hectic lifestyle, aged population, rising obesity etc. The rise of geriatric population in countries such as Japan, China, and India is also accounting the growth in this region. Rheumatic diseases are a major cause of morbidity in Latin America. The region has undergone an epidemiological transition in recent years. Middle East & Africa is estimated to witness steady growth during the forecast period owing to increasing rheumatic diseases patient pool.
Some of the key players operating in the rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Takeda Pharmaceutical and Sanofi.
Request customized copy of report @ https://www.zionmarketresearch.com/custom/2616
This report segments the rheumatology therapeutics market as follows:
Global Rheumatology Therapeutics Market: Disease Type Analysis
- Rheumatoid Arthritis
- Osteoarthritis
- Lupus
- Gout
Global Rheumatology Therapeutics Market: Drug Type Analysis
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
- Analgesics
- Disease Modifying Anti-Rheumatic Drugs (DMARDs)
- Corticosteroids
- Others
Global Rheumatology Therapeutics Market: Distribution Channel Analysis
- Retail Pharmacy
- Online Pharmacy
- Hospitals
- Other
Global Rheumatology Therapeutics Market: Regional Analysis
- North America
- The U.S.
- Canada
- Rest of North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Qatar
- Rest of the Middle East and Africa
Related Reports:
- IoT Healthcare Market: https://www.zionmarketresearch.com/report/iot-healthcare-market
- Home Infusion Therapy Market: https://www.zionmarketresearch.com/report/home-infusion-therapy-market
- Telemedicine Market: https://www.zionmarketresearch.com/report/telemedicine-market
- Therapeutic Vaccines Market: https://www.zionmarketresearch.com/report/therapeutic-vaccines-market
- Teleradiology Market: https://www.zionmarketresearch.com/report/teleradiology-market
About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research